Markus Schwaiger, MD, Receives SNMMI Georg Charles de Hevesy Nuclear Pioneer Award
Markus Schwaiger, MD, was named this year’s recipient of the Georg Charles de Hevesy Nuclear Pioneer Award at SNMMI's Annual Meeting.
Markus Schwaiger, MD, was named this year’s recipient of the Georg Charles de Hevesy Nuclear Pioneer Award at SNMMI's Annual Meeting.
PET/CT has been proven successful in evaluating lung inflammation and monitoring treatment in patients with post-COVID-19 lung disease.
MITA and other groups sent a letter to members of Congress requesting they hold hearings to consider the FIND Act of 2021 (H.R. 4479).
New research has confirmed the accuracy of the novel European Association of Urology (EAU) risk classification system that groups prostate cancer patients based on their risk of recurrence.
Read MoreBy combining information from two advanced imaging techniques with clinical data, physicians can improve their prediction of heart attacks, according to research published in The Journal of Nuclear Medicine
Read MoreThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and peer medical groups have issued appropriate use criteria for prostate-specific membrane antigen PET imaging.
Read MoreJohns Hopkins Medicine researchers have shown that PET scans can be used to “see” the movement of the drug rifampin in a living body, so that it can better treat bacterial infections attacking orthopedic implant-assisted bone.
Read MoreThe Radiological Society of North America (RSNA) is teaming up with RadSite, an accreditation organization for advanced diagnostic imaging, to pilot the RSNA Quantitative Imaging Biomarkers Alliance Profile for fluorodeoxyglucose (FDG) PET/CT imaging.
Read More